These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 25131955

  • 1. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
    Zhao X, Wang Y, Pang Y.
    Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955
    [Abstract] [Full Text] [Related]

  • 2. [Genetic research about Mycobacterium avium complex].
    Ogawa K.
    Kekkaku; 2011 Feb; 86(2):61-8. PubMed ID: 21404652
    [Abstract] [Full Text] [Related]

  • 3. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.
    Zheng HW, Pang Y, He GX, Song YY, Zhao YL.
    Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811
    [Abstract] [Full Text] [Related]

  • 4. [Antimicrobial susceptibility and genotyping of Mycobacterium intracellulare].
    Wang SQ, Jiang GL, Wei GM, Huo FM, Dong LL, Zhao LP, Huang HR, Wang GR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jul 12; 41(7):539-543. PubMed ID: 29996350
    [Abstract] [Full Text] [Related]

  • 5. Genetic research about Mycobacterium avium complex.
    Ogawa K.
    Kekkaku; 2013 Jan 12; 88(1):17-22. PubMed ID: 23513564
    [Abstract] [Full Text] [Related]

  • 6. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A.
    Kekkaku; 2011 Feb 12; 86(2):113-25. PubMed ID: 21404655
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility testing and genotyping of Mycobacterium avium isolates of two tertiary tuberculosis designated hospital, China.
    Wei G, Huang M, Wang G, Huo F, Dong L, Li Y, Huang H.
    Infect Genet Evol; 2015 Dec 12; 36():141-146. PubMed ID: 26391006
    [Abstract] [Full Text] [Related]

  • 8. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
    Yamaba Y, Ito Y, Suzuki K, Kikuchi T, Ogawa K, Fujiuchi S, Hasegawa N, Kurashima A, Higuchi T, Uchiya KI, Watanabe A, Niimi A.
    J Infect Chemother; 2019 Dec 12; 25(12):995-1000. PubMed ID: 31239192
    [Abstract] [Full Text] [Related]

  • 9. PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.
    Hirama T, Shiono A, Egashira H, Kishi E, Hagiwara K, Nakamura H, Kanazawa M, Nagata M.
    J Clin Microbiol; 2016 Mar 12; 54(3):699-704. PubMed ID: 26739154
    [Abstract] [Full Text] [Related]

  • 10. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Lee MR, Chien JY, Huang YT, Liao CH, Shu CC, Yu CJ, Hsueh PR.
    Int J Antimicrob Agents; 2017 Jul 12; 50(1):35-40. PubMed ID: 28478210
    [Abstract] [Full Text] [Related]

  • 11. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.
    J Clin Microbiol; 2019 Aug 12; 57(8):. PubMed ID: 31167842
    [Abstract] [Full Text] [Related]

  • 12. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr 12; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC, Wu MF, Chen HC, Huang WC.
    J Microbiol Immunol Infect; 2018 Oct 12; 51(5):636-643. PubMed ID: 28705770
    [Abstract] [Full Text] [Related]

  • 14. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z, Pang Y, Wang Y, Cohen C, Zhao Y, Liu C.
    Int J Antimicrob Agents; 2015 May 12; 45(5):491-5. PubMed ID: 25795316
    [Abstract] [Full Text] [Related]

  • 15. Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles.
    Truden S, Žolnir-Dovč M, Sodja E, Starčič Erjavec M.
    Infect Genet Evol; 2020 Aug 12; 82():104311. PubMed ID: 32247868
    [Abstract] [Full Text] [Related]

  • 16. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May 12; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F, Loiseau J, Veziris N, Bernard C, Bercot B, Sougakoff W, Jarlier V, Raskine L, Cambau E, French National Reference Center for Mycobacteria.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1669-1677. PubMed ID: 28333340
    [Abstract] [Full Text] [Related]

  • 18. Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates.
    Lee SH, Park YK, Kim CK, Kim HJ.
    J Clin Lab Anal; 2011 Jun 01; 25(1):33-6. PubMed ID: 21254240
    [Abstract] [Full Text] [Related]

  • 19. Molecular typing of Mycobacterium intracellulare using multilocus variable-number of tandem-repeat analysis: identification of loci and analysis of clinical isolates.
    Ichikawa K, Yagi T, Inagaki T, Moriyama M, Nakagawa T, Uchiya KI, Nikai T, Ogawa K.
    Microbiology (Reading); 2010 Feb 01; 156(Pt 2):496-504. PubMed ID: 19850613
    [Abstract] [Full Text] [Related]

  • 20. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K.
    Kekkaku; 2006 Apr 01; 81(4):329-35. PubMed ID: 16715941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.